135 related articles for article (PubMed ID: 9805656)
21. Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies.
Epel M; Carmi I; Soueid-Baumgarten S; Oh S; Bera T; Pastan I; Berzofsky J; Reiter Y
Eur J Immunol; 2008 Jun; 38(6):1706-20. PubMed ID: 18446790
[TBL] [Abstract][Full Text] [Related]
22. Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes.
Bodmer H; Ogg G; Gotch F; McMichael A
Nature; 1989 Nov; 342(6248):443-6. PubMed ID: 2479838
[TBL] [Abstract][Full Text] [Related]
23. Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit.
Lev A; Denkberg G; Cohen CJ; Tzukerman M; Skorecki KL; Chames P; Hoogenboom HR; Reiter Y
Cancer Res; 2002 Jun; 62(11):3184-94. PubMed ID: 12036932
[TBL] [Abstract][Full Text] [Related]
24. Tax and M1 peptide/HLA-A2-specific Fabs and T cell receptors recognize nonidentical structural features on peptide/HLA-A2 complexes.
Biddison WE; Turner RV; Gagnon SJ; Lev A; Cohen CJ; Reiter Y
J Immunol; 2003 Sep; 171(6):3064-74. PubMed ID: 12960332
[TBL] [Abstract][Full Text] [Related]
25. Flexibility in T-cell receptor ligand repertoires depends on MHC and T-cell receptor clonotype.
Geluk A; van Meijgaarden KE; Ottenhoff TH
Immunology; 1997 Mar; 90(3):370-5. PubMed ID: 9155643
[TBL] [Abstract][Full Text] [Related]
26. Short peptide sequences mimic HLA-DM functions.
Chou CL; Mirshahidi S; Su KW; Kim A; Narayan K; Khoruzhenko S; Xu M; Sadegh-Nasseri S
Mol Immunol; 2008 Apr; 45(7):1935-43. PubMed ID: 18054387
[TBL] [Abstract][Full Text] [Related]
27. An HLA-DRB1-derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs.
Snijders A; Elferink DG; Geluk A; van Der Zanden AL; Vos K; Schreuder GM; Breedveld FC; de Vries RR; Zanelli EH
J Immunol; 2001 Apr; 166(8):4987-93. PubMed ID: 11290778
[TBL] [Abstract][Full Text] [Related]
28. T cell recognition of allopeptides in context of syngeneic MHC.
Liu Z; Braunstein NS; Suciu-Foca N
J Immunol; 1992 Jan; 148(1):35-40. PubMed ID: 1530797
[TBL] [Abstract][Full Text] [Related]
29. Degeneracy of T cell receptor recognition of an influenza virus hemagglutinin epitope restricted by HLA-DQ and -DR class II molecules.
Jones CM; Lake RA; Lamb JR; Faith A
Eur J Immunol; 1994 May; 24(5):1137-42. PubMed ID: 7514130
[TBL] [Abstract][Full Text] [Related]
30. Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E.
Karp DR; Long EO
J Exp Med; 1992 Feb; 175(2):415-24. PubMed ID: 1370684
[TBL] [Abstract][Full Text] [Related]
31. Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides.
Newton-Nash DK; Eckels DD
J Immunol; 1993 Mar; 150(5):1813-21. PubMed ID: 7679697
[TBL] [Abstract][Full Text] [Related]
32. HLA-DO as the optimizer of epitope selection for MHC class II antigen presentation.
Poluektov YO; Kim A; Hartman IZ; Sadegh-Nasseri S
PLoS One; 2013; 8(8):e71228. PubMed ID: 23951115
[TBL] [Abstract][Full Text] [Related]
33. Interactions between the amino-terminal domains of MHC class II molecules have a profound effect on serologic and T cell recognition: an analysis using recombinant HLA-DR/H-2E molecules.
Barber LD; Lechler RI
J Immunol; 1991 Oct; 147(7):2346-53. PubMed ID: 1717556
[TBL] [Abstract][Full Text] [Related]
34. A mAb against HLA-A2 can be influenced both positively and negatively by the associated peptide.
Barouch D; Davenport M; McMichael A; Reay P
Int Immunol; 1995 Oct; 7(10):1599-605. PubMed ID: 8562505
[TBL] [Abstract][Full Text] [Related]
35. Induction of MHC-class I restricted human suppressor T cells by peptide priming in vitro.
Jiang S; Tugulea S; Pennesi G; Liu Z; Mulder A; Lederman S; Harris P; Cortesini R; Suciu-Foca N
Hum Immunol; 1998 Nov; 59(11):690-9. PubMed ID: 9796737
[TBL] [Abstract][Full Text] [Related]
36. Lymphocyte responses to DR1/4 restricted peptides in rheumatoid arthritis.
Skinner MA; Watson L; Geursen A; Tan PL
Ann Rheum Dis; 1994 Mar; 53(3):171-7. PubMed ID: 8154934
[TBL] [Abstract][Full Text] [Related]
37. Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex.
Heemskerk MH; de Paus RA; Lurvink EG; Koning F; Mulder A; Willemze R; van Rood JJ; Falkenburg JH
Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6806-11. PubMed ID: 11381117
[TBL] [Abstract][Full Text] [Related]
38. Monoclonal antibodies specific for the empty conformation of HLA-DR1 reveal aspects of the conformational change associated with peptide binding.
Carven GJ; Chitta S; Hilgert I; Rushe MM; Baggio RF; Palmer M; Arenas JE; Strominger JL; Horejsi V; Santambrogio L; Stern LJ
J Biol Chem; 2004 Apr; 279(16):16561-70. PubMed ID: 14757758
[TBL] [Abstract][Full Text] [Related]
39. A major histocompatibility complex-peptide-restricted antibody and t cell receptor molecules recognize their target by distinct binding modes: crystal structure of human leukocyte antigen (HLA)-A1-MAGE-A1 in complex with FAB-HYB3.
Hülsmeyer M; Chames P; Hillig RC; Stanfield RL; Held G; Coulie PG; Alings C; Wille G; Saenger W; Uchanska-Ziegler B; Hoogenboom HR; Ziegler A
J Biol Chem; 2005 Jan; 280(4):2972-80. PubMed ID: 15537658
[TBL] [Abstract][Full Text] [Related]
40. Involvement of class II beta-chain amino acid residues 85 and 86 in T-cell allorecognition.
Eckels DD; Geiger MJ; Sell TW; Gorski JA
Hum Immunol; 1990 Mar; 27(3):240-53. PubMed ID: 1692822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
